ArticleFrontiers in pharmacology2021

Identification of a RAD52 Inhibitor Inducing Synthetic Lethality in BRCA2-Deficient Cancer Cells.

Qianye Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.